再鼎医药(09688)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09688 再鼎医药

提前休市 02-16 12:08:06

15.160

-0.430

-2.76%

最高15.530	最低15.120	成交量158.85万
今开15.500	昨收15.590	日振幅2.63%
总市值171.00亿	流通市值171.00亿	总股本11.28亿
成交额2,423万	换手率0.14%	流通股本11.28亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09688","market":"HK","secType":"STK","nameCN":"再鼎医药","latestPrice":15.16,"timestamp":1771214886005,"preClose":15.59,"halted":0,"volume":1588500,"delay":0,"changeRate":-0.02758178319435534,"floatShares":1128000000,"shares":1128000000,"eps":-2.030674606896121,"marketStatus":"提前休市","change":-0.43,"latestTime":"02-16 12:08:06","open":15.5,"high":15.53,"low":15.12,"amount":24230263,"amplitude":0.026299,"askPrice":15.3,"askSize":9800,"bidPrice":15.16,"bidSize":13600,"shortable":3,"etf":0,"ttmEps":-1.5027587608240336,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771551000000},"marketStatusCode":6,"adr":0,"listingDate":1601222400000,"exchange":"SEHK","adjPreClose":15.59,"openAndCloseTimeList":[[1771205400000,1771214400000]],"volumeRatio":0.277532,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09688/wiki","defaultTab":"wiki","newsList":[{"id":"2611167605","title":"再鼎医药涨逾7% 注射用ZL-1310拟纳入突破性疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=2611167605","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611167605?lang=zh_cn&edition=full","pubTime":"2026-02-13 22:43","pubTimestamp":1770993782,"startTime":"0","endTime":"0","summary":"周五，再鼎医药(ZLAB.US)涨逾7%，报20.11美元。消息面上，2月9日，再鼎医药的注射用ZL-1310拟纳入突破性疗法，拟用于一线含铂治疗期间或治疗后出现疾病进展的广泛期小细胞肺癌(ES-SCLC)患者。ZL-1310在早期临床研究中展现出的疗效数据非常突出，尤其是在二线及以上治疗和脑转移患者中均显示出高缓解率，使其有潜力成为SCLC治疗领域的突破性疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213224645a4a13d82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213224645a4a13d82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1588","09688","BK1161","LU2488822045.USD","BK1574"],"gpt_icon":0},{"id":"2611137561","title":"每日卖空追踪 | 再鼎医药 02月13日卖空量成交83.12万股，卖空比例为4.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611137561","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611137561?lang=zh_cn&edition=full","pubTime":"2026-02-13 16:30","pubTimestamp":1770971443,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间02月13日，涨7.37%，卖空量成交83.12万股，较上一交易日增加10.09%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213163651a6f6e809&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213163651a6f6e809&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09688","BK1161","BK1588","LU2488822045.USD"],"gpt_icon":0},{"id":"2611676031","title":"再鼎医药将于2026年2月26日公布2025年第四季度及全年财务业绩和近期公司进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2611676031","media":"再鼎医药","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611676031?lang=zh_cn&edition=full","pubTime":"2026-02-13 15:04","pubTimestamp":1770966270,"startTime":"0","endTime":"0","summary":"公司将于美国东部时间2026年2月26日上午8:00召开电话会议和网络直播中国上海和美国马萨诸塞州剑桥，再鼎医药有限公司宣布，将于美国东部时间2026年2月26日美国股市开盘前公布2025年第四季度及全年财务业绩和近期公司动态。关于再鼎医药再鼎医药是一家以研发为基础、处于商业化阶段的创新型生物制药公司，总部位于中国和美国。我们的目标是利用我们的能力和资源为人类健康带来积极影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021315500195410403&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021315500195410403&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09688","BK1161","BK1588","LU2488822045.USD"],"gpt_icon":0},{"id":"2611937183","title":"港股异动 | 再鼎医药(09688)再涨超5% ZL-1310拟纳入突破性疗法 有望成为SCLC治疗领域突破性疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=2611937183","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611937183?lang=zh_cn&edition=full","pubTime":"2026-02-13 10:52","pubTimestamp":1770951178,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，再鼎医药再涨超5%，截至发稿，涨5.1%，报15.26港元，成交额8197.41万港元。消息面上，2月9日，再鼎医药的注射用ZL-1310拟纳入突破性疗法，拟用于一线含铂治疗期间或治疗后出现疾病进展的广泛期小细胞肺癌患者。ZL-1310在早期临床研究中展现出的疗效数据非常突出，尤其是在二线及以上治疗和脑转移患者中均显示出高缓解率，使其有潜力成为SCLC治疗领域的突破性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405021.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4548","BK4588","LU2488822045.USD","VT","BK1161","ZLAB","BK4531","BK1574","BK4526","BK4139","BK1588","09688","BK4585","VXUS"],"gpt_icon":0},{"id":"2611540137","title":"再鼎医药盘中异动 早盘股价大涨5.03%报15.250港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611540137","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611540137?lang=zh_cn&edition=full","pubTime":"2026-02-13 10:42","pubTimestamp":1770950566,"startTime":"0","endTime":"0","summary":"2026年02月13日早盘10时42分，再鼎医药股票出现异动，股价大幅拉升5.03%。截至发稿，该股报15.250港元/股，成交量427.9万股，换手率0.38%，振幅5.30%。资金方面，该股资金流入3695.46万港元，流出1721.87万港元。再鼎医药股票所在的生物技术行业中，整体跌幅为1.48%。其相关个股中，再鼎医药、中国抗体-B、映恩生物-B涨幅较大，振幅较大的相关个股有北海康成-B、荃信生物-B、中国抗体-B，振幅分别为10.45%、7.37%、6.15%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213104246a6f5b3a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213104246a6f5b3a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","LU2488822045.USD","09688","BK1588"],"gpt_icon":0},{"id":"2610195534","title":"再鼎医药(09688.HK)拟于2月26日审议及发布2025年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2610195534","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610195534?lang=zh_cn&edition=full","pubTime":"2026-02-11 22:07","pubTimestamp":1770818826,"startTime":"0","endTime":"0","summary":"格隆汇2月11日丨再鼎医药(09688.HK)公布，公司董事会将于2026年2月26日(星期四)审议及批准(其中包括)根据美国公认会计准则(“美国公认会计准则”)及美国证券交易委员会(“美国证交会”)的适用规则编制的公司及其附属公司截至2025年12月31日止年度的财务业绩(“年度业绩”)及其发布。\r\n\r\n　　倘年度业绩获董事会批准，公司将于2026年2月26日(星期四)在香港联合交易所有限公司网站www.hkexnews.hk及公司网站http://ir.zailaboratory.com发布关于年度业绩的公告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260211/32013321.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["09688","BK1588","ZLAB","BK1574","BK4139","BK4526","BK4531","BK4548","BK4585","BK1161","BK4588","LU2488822045.USD"],"gpt_icon":0},{"id":"2610179607","title":"每日卖空追踪 | 再鼎医药 02月10日卖空量成交85.4万股，卖空比例为4.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610179607","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610179607?lang=zh_cn&edition=full","pubTime":"2026-02-10 16:30","pubTimestamp":1770712244,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间02月10日，涨3.2%，卖空量成交85.4万股，较上一交易日增加46.71%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210163628a6e9b042&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210163628a6e9b042&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09688","BK1588","BK1574","LU2488822045.USD"],"gpt_icon":0},{"id":"2610493607","title":"再鼎医药02月10日主力净流入2173.2万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2610493607","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610493607?lang=zh_cn&edition=full","pubTime":"2026-02-10 16:15","pubTimestamp":1770711343,"startTime":"0","endTime":"0","summary":"02月10日, 再鼎医药股价涨3.20%，报收14.52元，成交金额2.5亿元，换手率1.52%，振幅4.98%，量比1.94。再鼎医药今日主力资金净流入2173.2万元，上一交易日主力净流出195.8万元。该股近5个交易日上涨10.46%，主力资金累计净流入2122.3万元；近20日主力资金累计净流入1872.6万元，其中净流入天数为10日。该股主力净额占比0.13%，港股市场排名60/2717。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210161913a6e999dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210161913a6e999dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09688","BK1574","BK1588","BK1161","LU2488822045.USD"],"gpt_icon":0},{"id":"2610268695","title":"恒生医疗保健指数升2.17%  医药板块普遍拉升 机构持续看好中国创新药出海的产业趋势","url":"https://stock-news.laohu8.com/highlight/detail?id=2610268695","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610268695?lang=zh_cn&edition=full","pubTime":"2026-02-10 09:59","pubTimestamp":1770688793,"startTime":"0","endTime":"0","summary":"2月8日，信达生物宣布与礼来制药达成战略合作，携手推进肿瘤及免疫领域创新药物的全球研发。2026年，继续看好中国创新药出海的产业趋势，继续重点跟踪ADC、双抗、小核酸、减肥药等核心优势赛道的投资机会，期待JPM大会、ASCO等带来数据更新和BD催化。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/OTEzM2QyMzQzMjc2MzA3OTk2MA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OTEzM2QyMzQzMjc2MzA3OTk2MA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"8f73ea90e21e93e4b02cf2f8986a9c30","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1974845","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969","LU1969619763.USD","LU0043850808.USD","09688","01548","BK1161","02268","LU2476274308.USD","LU2242644610.SGD","01877","LU0572944931.SGD","06978","02269","LU0516422366.SGD","LU1961090484.USD","LU0348825331.USD","09926","LU0502904849.HKD","LU2045819591.USD","159506","03347","LU0196878994.USD","LU0417516738.SGD","IE00B5MMRT66.SGD","159992","06990","159938","LU2488822045.USD","LU0417516902.SGD","LU0140636845.USD","LU1688375341.USD","09995","LU2476274720.SGD","LU1046422090.SGD","BK1587","LU1720050803.USD","HK0000306701.USD","LU0823426308.USD","LU2039709279.SGD","LU0051755006.USD","02162","LU0181495838.USD","LU0856984785.SGD","09939","02696","LU0359202008.SGD","LU0634319403.HKD","02359","01801","LU0516423174.USD"],"gpt_icon":1},{"id":"2609362512","title":"每日卖空追踪 | 再鼎医药 02月06日卖空量成交23.25万股，卖空比例为3.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609362512","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609362512?lang=zh_cn&edition=full","pubTime":"2026-02-06 16:30","pubTimestamp":1770366643,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间02月06日，跌0.59%，卖空量成交23.25万股，较上一交易日减少77.35%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206163749a483d28d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206163749a483d28d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09688","LU2488822045.USD","BK1574","BK1161","BK1588"],"gpt_icon":0},{"id":"2609363512","title":"再鼎医药02月06日主力净流出525.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2609363512","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609363512?lang=zh_cn&edition=full","pubTime":"2026-02-06 16:15","pubTimestamp":1770365747,"startTime":"0","endTime":"0","summary":"02月06日, 再鼎医药股价跌0.59%，报收13.55元，成交金额9669.6万元，换手率0.64%，振幅3.23%，量比0.66。再鼎医药今日主力资金净流出525.1万元，上一交易日主力净流入614.3万元。该股近5个交易日上涨3.50%，主力资金累计净流出109.1万元；近20日主力资金累计净流出535.5万元，其中净流出天数为10日。该股主力净额占比0.03%，港股市场排名2598/2715。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206161957a6dab046&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206161957a6dab046&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09688","BK1588","BK1574","LU2488822045.USD"],"gpt_icon":0},{"id":"1118675131","title":"再鼎医药（09688）2026年1月股份变动月报：股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1118675131","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118675131?lang=zh_cn&edition=full","pubTime":"2026-02-05 22:40","pubTimestamp":1770302446,"startTime":"0","endTime":"0","summary":"再鼎医药有限公司于2026年2月5日披露2026年1月股份变动月报表。截至1月31日，公司注册股本维持5,000,000,000股，面值为每股0.000006美元，注册股本总额继续保持30,000美元。报告期内，已发行普通股总数维持在1,119,628,030股，未有新增发行、回购或注销股份活动。公告显示，公司符合适用的公眾持股量要求。公司在公告中确认，所有股份发行及转让活动均遵守香港联交所《上市规则》及其他法律法规。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09688"],"gpt_icon":0},{"id":"1197197181","title":"港股生物医药板块走高，诺诚健华、再鼎医药涨超4%，药明康德、药明生物等个股跟涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1197197181","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197197181?lang=zh_cn&edition=full","pubTime":"2026-02-05 15:24","pubTimestamp":1770276262,"startTime":"0","endTime":"0","summary":"2月5日，港股$生物(000504)$医药板块走高，$诺诚健华(09969)$、$再鼎医药(09688)$涨超4%，$药明康德(02359)$、$药明$生物(000504)$(02269)$等个股跟涨。","market":"hk","thumbnail":"https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4d7f9f320a213719065b5b2c9bc96e8b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1046422090.SGD","LU1934453819.USD","LU0348825331.USD","LU2039709279.SGD","LU0417516738.SGD","02359","SG9999002562.SGD","LU0516422366.SGD","LU2125910500.SGD","LU0327786744.USD","BK1610","LU1808992512.USD","LU0307460666.USD","LU1880383366.USD","02269","BK1574","LU0823426308.USD","LU3063872942.SGD","LU1242518857.USD","BK1161","BK1588","LU2495084118.USD","09688","399441","LU1997245177.USD","BK4526","BK4139","LU0516423174.USD","LU0979878070.USD","LU1242518931.SGD","BK1576","LU0819121731.USD","SG9999002463.SGD","LU0359201612.USD","BK0239","LU0039217434.USD","LU1997245094.SGD","IE00B0JY6N72.USD","BK4531","LU0320764599.SGD","LU1997244956.HKD","LU0052750758.USD","LU0051755006.USD","LU0456842615.SGD","LU0348735423.USD","LU0456827905.SGD","BK1583","LU0359202008.SGD","LU0823426480.USD","BK1589","LU2242644610.SGD","LU0856984785.SGD","LU0456846285.SGD","LU0588546209.SGD","LU0140636845.USD","LU0708995583.HKD","LU0043850808.USD","BK4585","LU0572944931.SGD","LU0516422440.USD","BK1141","09969","LU0417516902.SGD","LU0516422952.EUR","LU2045819591.USD","LU0181495838.USD","LU1794554557.SGD","LU0326950275.SGD","BK0216","LU1720050803.USD","LU2328871848.SGD","LU2488822045.USD","LU1979443071.USD","LU1688375341.USD","BK4548","LU1969619763.USD","LU0516423091.SGD","BK1521","BK4588"],"gpt_icon":0},{"id":"2608936821","title":"摩根大通增持再鼎医药(09688)约192.01万股 每股作价约13.34港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608936821","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608936821?lang=zh_cn&edition=full","pubTime":"2026-02-04 19:00","pubTimestamp":1770202840,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，1月30日，摩根大通增持再鼎医药(09688)192.0096万股，每股作价13.3426港元，总金额约为2561.91万港元。增持后最新持股数目约为5647.03万股，最新持股比例为5.04%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1401682.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09688","LU1720051017.SGD","LU1363072403.SGD","BK1574","LU1894683264.USD","BK4533","LU0320765489.SGD","LU2211815571.USD","LU2242649171.HKD","LU1496350171.SGD","BK4139","LU2756315664.SGD","LU2264538146.SGD","IE00BZ1G4Q59.USD","LU0345770308.USD","LU1670628061.USD","IE00B775SV38.USD","LU0496365809.HKD","IE00BFXG1179.USD","LU1720051108.HKD","LU1894683348.USD","LU2746668461.USD","LU1988902786.USD","LU0882574139.USD","LU1244550494.USD","IE00BDCRKT87.USD","LU2237443549.SGD","ZLAB","BK4531","LU2237443978.SGD","LU2552382215.SGD","LU0267386448.USD","LU0976567544.SGD","LU1032466523.USD","BK4566","LU0964807845.USD","LU1244550221.USD","LU2505996509.AUD","BK1588","LU2023250843.SGD","LU2213496289.HKD","IE00B3S45H60.SGD","LU0070302665.USD","IE00BKDWB100.SGD","LU1668664300.SGD","LU1974910355.USD","LU1548497426.USD","LU2505996681.GBP","LU1267930490.SGD","LU1366192091.USD"],"gpt_icon":0},{"id":"2608354739","title":"每日卖空追踪 | 再鼎医药 02月04日卖空量成交51.18万股，卖空比例为7.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608354739","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608354739?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:30","pubTimestamp":1770193842,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间02月04日，涨0.38%，卖空量成交51.18万股，较上一交易日减少79.35%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163857a47b11a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163857a47b11a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","LU2488822045.USD","09688","BK1161","BK1588"],"gpt_icon":0},{"id":"2608354736","title":"再鼎医药02月04日获主力加仓55.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608354736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608354736?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:15","pubTimestamp":1770192955,"startTime":"0","endTime":"0","summary":"02月04日, 再鼎医药股价涨0.38%，报收13.15元，成交金额8702.7万元，换手率0.59%，振幅4.20%，量比0.59。再鼎医药今日主力资金净流入55.6万元，上一交易日主力净流入98.7万元。该股近5个交易日下跌5.21%，主力资金累计净流出2551.1万元；近20日主力资金累计净流出985.7万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204162208a6d1f4b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204162208a6d1f4b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","BK1588","09688","LU2488822045.USD"],"gpt_icon":0},{"id":"2608805578","title":"每日卖空追踪 | 再鼎医药 02月03日卖空量成交103.06万股，卖空比例为8.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608805578","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608805578?lang=zh_cn&edition=full","pubTime":"2026-02-03 16:30","pubTimestamp":1770107441,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间02月03日，涨5.31%，卖空量成交103.06万股，较上一交易日减少58.7%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203163742a6cdbaec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203163742a6cdbaec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1588","BK1161","BK1574","09688","LU2488822045.USD"],"gpt_icon":0},{"id":"2608180557","title":"再鼎医药02月03日主力净流入98.7万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2608180557","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608180557?lang=zh_cn&edition=full","pubTime":"2026-02-03 16:15","pubTimestamp":1770106529,"startTime":"0","endTime":"0","summary":"02月03日, 再鼎医药股价涨5.31%，报收13.10元，成交金额1.5亿元，换手率1.06%，振幅4.98%，量比1.11。再鼎医药今日主力资金净流入98.7万元，上一交易日主力净流出352.7万元。该股近5个交易日下跌4.45%，主力资金累计净流出2568.4万元；近20日主力资金累计净流出283.5万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203161720a6cda2d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203161720a6cda2d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1161","BK1574","BK1588","09688"],"gpt_icon":0},{"id":"2608858816","title":"【券商聚焦】浦银国际维持再鼎医药(09688)“买入”评级 料公司有望在2027年迎来净利润端的盈亏平衡","url":"https://stock-news.laohu8.com/highlight/detail?id=2608858816","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608858816?lang=zh_cn&edition=full","pubTime":"2026-02-02 14:59","pubTimestamp":1770015599,"startTime":"0","endTime":"0","summary":"基于公司近况以及短中期商业化展望，该机构将2025E/2026E净亏损预测调整为1.9亿美元/2.1亿美元，该机构预计公司有望在2027年迎来净利润端的盈亏平衡。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250106/ODRhMzI4MWM5YTc2MTY1NjgxNGQwMTEwODUwOTcyNzQ0Mg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ODRhMzI4MWM5YTc2MTY1NjgxNGQwMTEwODUwOTcyNzQ0Mg==.jpg"],"rights":null,"property":["rate","earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1974391","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZLAB","09688"],"gpt_icon":0},{"id":"2607028878","title":"再鼎医药01月30日主力净流出2473.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2607028878","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607028878?lang=zh_cn&edition=full","pubTime":"2026-01-30 16:16","pubTimestamp":1769760967,"startTime":"0","endTime":"0","summary":"01月30日, 再鼎医药股价跌3.24%，报收13.13元，成交金额1.5亿元，换手率1.03%，振幅4.57%，量比1.22。该股近5个交易日下跌6.31%，主力资金累计净流出2666.3万元；近20日主力资金累计净流入1145.3万元，其中净流入天数为11日。该股主力净额占比0.17%，港股市场排名2658/2707。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130162715a4684652&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130162715a4684652&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09688","LU2488822045.USD","BK1574","BK1588","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zailaboratory.com","stockEarnings":[{"period":"1week","weight":0.1506},{"period":"1month","weight":0.0071},{"period":"3month","weight":-0.0888},{"period":"6month","weight":-0.438},{"period":"1year","weight":-0.3025},{"period":"ytd","weight":0.1421}],"compareEarnings":[{"period":"1week","weight":0.0003},{"period":"1month","weight":-0.016},{"period":"3month","weight":-0.0187},{"period":"6month","weight":0.0513},{"period":"1year","weight":0.2179},{"period":"ytd","weight":0.0365}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"再鼎医药有限公司是一家主要从事生物制药业务的控股公司。该公司致力于通过产品的发现、开发和商业化解决肿瘤、免疫、神经科学和感染性疾病领域未被满足的医疗需求。该公司拥有从发现阶段到临床项目后期的一系列专利候选药物，其中包括“则乐”、“OPTUNE”、“擎乐”、“纽再乐”及“卫伟迦”等。该公司在国内市场和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.017355},{"month":2,"riseRate":0.666667,"avgChangeRate":0.075582},{"month":3,"riseRate":0.2,"avgChangeRate":-0.100669},{"month":4,"riseRate":0.6,"avgChangeRate":0.032813},{"month":5,"riseRate":0.4,"avgChangeRate":-0.024133},{"month":6,"riseRate":0.4,"avgChangeRate":-0.013792},{"month":7,"riseRate":0.8,"avgChangeRate":0.065752},{"month":8,"riseRate":0.6,"avgChangeRate":-0.021717},{"month":9,"riseRate":0.4,"avgChangeRate":-0.054178},{"month":10,"riseRate":0.5,"avgChangeRate":-0.051338},{"month":11,"riseRate":0.5,"avgChangeRate":0.047251},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.024481}],"exchange":"SEHK","name":"再鼎医药","nameEN":"ZAI LAB"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"再鼎医药(09688)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供再鼎医药(09688)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"再鼎医药,09688,再鼎医药股票,再鼎医药股票老虎,再鼎医药股票老虎国际,再鼎医药行情,再鼎医药股票行情,再鼎医药股价,再鼎医药股市,再鼎医药股票价格,再鼎医药股票交易,再鼎医药股票购买,再鼎医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"再鼎医药(09688)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供再鼎医药(09688)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}